Suchergebnisse - "Zheng, Mei-Mei"

PubPharm (23)

1

Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8) : a multi-center, single-arm, phase 2 trial

enthalten in: EClinicalMedicine | 2023

von Maggie Liu, S. | Dong, X. | Wang, Z. | +23

2

Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy

enthalten in: Molecular oncology | 2023

von Tu, H. | Yin, K. | Zhao, X. | +19

3

Emerging evidence and treatment paradigm of non-small cell lung cancer

enthalten in: Journal of hematology & oncology | 2023

von Liu, S. | Zheng, M. | Pan, Y. | +3

4

Emerging evidence and treatment paradigm of non-small cell lung cancer

enthalten in: Journal of hematology & oncology | 2023

von Liu, S. | Zheng, M. | Pan, Y. | +3

5

Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC

enthalten in: Cancers | 2023

von Jie, G. | Peng, L. | Zheng, M. | +12

6

Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases

enthalten in: BMC medicine | 2022

von Zheng, M. | Li, Y. | Tu, H. | +11

7

Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases

enthalten in: BMC medicine | 2022

von Zheng, M. | Li, Y. | Tu, H. | +11

8

Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases

enthalten in: BMC medicine | 2022

von Zheng, M. | Li, Y. | Tu, H. | +11

9

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors

enthalten in: Experimental hematology & oncology | 2021

von Peng, L. | Jie, G. | Li, A. | +13

10

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors

enthalten in: Experimental hematology & oncology | 2021

von Peng, L. | Jie, G. | Li, A. | +13